Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.5%

6 terminated/withdrawn out of 71 trials

Success Rate

89.1%

+2.6% vs industry average

Late-Stage Pipeline

3%

2 trials in Phase 3/4

Results Transparency

31%

15 of 49 completed trials have results

Key Signals

7 recruiting15 with results

Enrollment Performance

Analytics

N/A
23(41.1%)
Phase 2
16(28.6%)
Phase 1
13(23.2%)
Early Phase 1
2(3.6%)
Phase 3
2(3.6%)
56Total
N/A(23)
Phase 2(16)
Phase 1(13)
Early Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (71)

Showing 20 of 71 trials
NCT05846789Phase 2Recruiting

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

Role: collaborator

NCT03587740Phase 2Active Not Recruiting

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Role: collaborator

NCT03546686Phase 2Active Not Recruiting

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Role: collaborator

NCT05654246Recruiting

Susan G. Komen's ShareForCures

Role: lead

NCT05721248Phase 2Active Not Recruiting

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

Role: collaborator

NCT03220893Not ApplicableCompleted

Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

Role: collaborator

NCT03368729Phase 1Active Not Recruiting

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

Role: collaborator

NCT05693766Phase 2Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

Role: collaborator

NCT03818087Active Not Recruiting

Elevate! : An Elderly Breast Cancer Cohort Study

Role: collaborator

NCT07014618Recruiting

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Role: collaborator

NCT03897270Not ApplicableRecruiting

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Role: collaborator

NCT01516190Not ApplicableActive Not Recruiting

The Preoperative Health & Body Study

Role: collaborator

NCT05978232Not ApplicableCompleted

NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients

Role: collaborator

NCT06436248Active Not Recruiting

Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

Role: collaborator

NCT07214610Not ApplicableRecruiting

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

Role: collaborator

NCT03716180Phase 1Active Not Recruiting

DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC

Role: collaborator

NCT01034033Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

Role: collaborator

NCT01349088Phase 1Withdrawn

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Role: collaborator

NCT01937039Active Not Recruiting

Johns Hopkins Breast Cancer Program Longitudinal Repository

Role: collaborator

NCT01818063Phase 2Completed

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Role: collaborator